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Abstract
Background: Alzheimer’s disease (AD) is characterized by the presence of early intraneuronal deposits of amyloid-b 42
(Ab42) that precede extracellular amyloid deposition in vulnerable brain regions. It has been hypothesized that endosomal/
lysosomal dysfunction might be associated with the pathological accumulation of intracellular Ab42 in the brain. Our
previous findings suggest that the LDL receptor-related protein 1 (LRP1), a major receptor for apolipoprotein E, facilitates
intraneuronal Ab42 accumulation in mouse brain. However, direct evidence of neuronal endocytosis of Ab42 through LRP1
is lacking.
Methodology/Principal Findings: Here we show that LRP1 endocytic function is required for neuronal Ab42 uptake.
Overexpression of a functional LRP1 minireceptor, mLRP4, increases Ab42 uptake and accumulation in neuronal lysosomes.
Conversely, knockdown of LRP1 expression significantly decreases neuronal Ab42 uptake. Disruptions of LRP1 endocytic
function by either clathrin knockdown or by removal of its cytoplasmic tail decreased both uptake and accumulation of
Ab42 in neurons. Finally, we show that LRP1-mediated neuronal accumulation of Ab42 is associated with increased cellular
toxicity.
Conclusions/Significance: These results demonstrate that LRP1 endocytic function plays an important role in the uptake
and accumulation of Ab42 in neuronal lysosomes. These findings emphasize the central function of LRP1 in neuronal Ab
metabolism.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder of the
central nervous system characterized by a progressive decline in
cognitive functions and neuronal loss. AD was originally attributed
to the accumulation of extracellular amyloid and intraneuronal tau
deposition [1]; however, mounting evidence indicates that
intracellular accumulation of amyloid-b 42 (Ab42) is an early
pathological marker that precedes neuronal cell death and
correlates with cognitive decline. Significant intraneuronal Ab42
is found in neuronal cell bodies of both AD patients and patients
with mild cognitive impairment, a preclinical condition that
precedes AD [2,3]. Animal models for AD corroborate the
presence of intraneuronal Ab42 prior to the appearance of
amyloid plaques. Functionally, intraneuronal Ab42 load is
associated with decreased long-term potentiation and increased
synaptotoxicity in Ab42-containing neurons [4,5,6]. Since the
endosomal/lysosomal pathway plays an important role in
mediating intracellular degradation of Ab, an impairment of this
pathway has been suggested as a possible mechanism for increased
neuronal Ab42 load within multivesicular bodies, especially in the
postsynaptic compartments [3,7,8]. The molecular mechanisms
that lead to Ab42 accumulation during AD are not clear. Recent
evidence indicates that autophagy, an upstream branch of the
endosomal/lysosomal cascade, is impaired in AD brains and
might be responsible for intraneuronal Ab42 accumulation [9]. In
addition to intraneuronal Ab production, Ab42 internalized from
extracellular space might represent a possible mechanism that
contributes to intracellular Ab42 accumulation [10,11,12,13,14].
Therefore, understanding the mechanisms of Ab42 internalization
is crucial for defining the neuropathological process of AD and for
designing novel methods of AD therapy.
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Apolipoprotein E (apoE) secreted by glia in the brain is required
for the internalization of lipoproteins by neuronal apoE receptors
and plays important roles in brain lipid transport and neuronal
repair [15]. It has been suggested that apoE regulates Ab42
accumulation in neurons during AD. Strong co-immunostaining of
intracellular apoE and Ab42 was evident in APP transgenic mice
[16]. The e4 allele of the APOE gene represents the most prevalent
genetic risk factor for late-onset AD [17,18,19], and apoE4 causes
lysosomal leakage when applied exogenously to cultured cells
[20,21]. Furthermore, apoE4 targeted-replacement mice induced
to accumulate endogenous Ab42 show increased neurodegener-
ation compared to apoE3 mice [22]. Notably, metabolism of both
apoE and Ab42 are regulated by the low-density lipoprotein (LDL)
receptor-related protein 1 (LRP1), a large endocytic receptor
belonging to the LDL receptor family [15].
LRP1 is synthesized as a 600-kDa precursor protein that interacts
with the ER chaperone receptor-associated protein (RAP) [23,24]
and matures in the biosynthetic pathway into an extracellular,
ligand-binding subunit of 515-kDa (LRP1-515) and a transmem-
brane 85-kDa subunit (LRP1-85) that binds several adaptor proteins
for efficient endocytic trafficking and signaling [25]. Several lines of
evidence suggest a role for LRP1 in AD pathogenesis and in the
metabolism of neuronal Ab42. 1. LRP1 is abundantly expressed in
the cell body and in proximal processes of cortical and hippocampal
neurons in the brain [26,27,28]. 2. LRP1 binds to Ab42 either
directly or via Ab chaperones such as apoE to mediate brain Ab
clearance [29,30,31]. 3. Several genetic risk factors for sporadic AD
are ligands of LRP1 which, together with LRP1, are found in senile
plaques in AD brains (for reviews see [31,32]. 4. In AD patients and
in elderly people, brain LRP1 levels are significantly decreased and
inversely correlate to the age of onset of AD, suggesting that a
decrease in LRP1 function might contribute to the cognitive decline
[33]. 5. Increased extracellular deposition of Ab42 was detected in
RAP-deficient mice, which display reduced levels of LRP1 [29]. 6.
Increased intraneuronal Ab42 was found in AD model mice
overexpressing a functional LRP1 minireceptor, mLRP2 [34].
Together, this evidence indicates a role for LRP1 in the etiology of
AD and suggests that LRP1 likely mediates neuronal Ab42 uptake
via receptor-mediated endocytosis. Despite these clues, direct
evidence supporting a role for LRP1 in neuronal Ab42 uptake
and accumulation is lacking. Here, using both gain-of-function and
loss-of-function approaches, we demonstrate a direct role for LRP1-
mediated endocytosis in neuronal Ab42 uptake and accumulation.
These studies define a novel receptor-mediated pathway for Ab42
entry to neuronal lysosomes, where Ab42 accumulation may
contribute to both Ab aggregation and neuronal toxicity.
Results
Overexpression of LRP1 increases Ab42 uptake and
accumulation in lysosomes in N2a cells
To test whether the endocytic activity of LRP1 mediates the
uptake of Ab42 and its accumulation within neurons, we analyzed
the uptake of fluorescently labeled Ab42 in control N2a cells and
in N2a cells that overexpress a LRP1 minireceptor, mLRP4. This
minireceptor contains the fourth ligand-binding domain of LRP1
and is capable of binding several LRP1 ligands with endocytic
properties identical to the full-length LRP1 [35]. We generated
stable N2a-mLRP4 and N2a-pcDNA3 cell lines and characterized
them for total mLRP4 expression levels by Western blot and
FACS (Fig. 1). Our results indicate that functional mLRP4 is
properly folded and matured in N2a cells, as evidenced by its
furin-induced cleavage into 120- and 85-kDa bands (Fig. 1A). To
determine if mLRP4 reached the plasma membrane after
synthesis, we analyzed cell surface levels of mLRP4 by FACS in
non-permeabilized cells. Approximately 80% of the cells showed
expression of cell surface mLRP4 (Fig. 1B). To assess whether cell
surface mLRP4 could interact and internalize ligands, we
performed uptake experiments with fluorescently labeled RAP.
RAP is an LRP1 chaperone of 39-kDa that binds LRP1 with high
affinity and is commonly used as a model extracellular ligand
for LRP1 [23,36]. Cell-associated RAP was primarily detected
intracellularly, as demonstrated by confocal microscopy
(Figure 1C) and increased in N2a-mLRP4 cells compared to
N2a-pcDNA3 cells. To quantify the amount of internalized RAP,
we performed FACS analysis of similarly treated cultures. Cells
were detached and additionally treated with pronase to remove
any cell-surface labeled RAP. N2a-mLRP4 cells have an 8-fold
increase in the uptake of fluorescently labeled RAP compared to
N2a-pcDNA3 cells (Fig. 1D), indicating that mLRP4 expressed in
N2a cells is fully functional in mediating ligand internalization.
Based on these results, we analyzed the uptake of Ab42 in N2a-
pcDNA3 cells and N2a-mLRP4 cells by performing binding/
endocytosis assays and fluorescence microcopy analysis. We
choose FAM-Ab42 as our amyloid-peptide probe since the
addition of the carboxyfluorescein moiety at the N-terminal
region does not change the properties of Ab42 aggregation and
internalization into neurons [37]. For binding-endocytosis exper-
iments, N2a-pcDNA3 and N2a-mLRP4 cells were first incubated
with 5 mMAb42 at 4uC for 1 h to allow the binding of Ab42. Cells
were then warmed to 37uC for different periods of time to allow
ligand internalization, and analyzed by confocal microscopy as
described in the Experimental Procedures section. N2a-pcDNA3 cells
accumulated a small amount of Ab42 after 8 h of warming; this
accumulated Ab42 disappeared by 24 h (Fig 1E). In contrast,
Ab42 uptake was faster and accumulation greater in N2a-mLRP4
cells, peaking at 4 h and decreasing over time. These results
indicate that increased FAM-Ab42 uptake occurred in N2a cells
overexpressing LRP1 minireceptor and demonstrate that the
lysosomal function is unaffected by LRP1 overexpression, given
the similar clearance rate of FAM-Ab42 in the two cell types
analyzed.
To determine whether internalized Ab42 is accumulated over
time, we performed continuous feeding experiments of FAM-
Ab42 in N2a-pcDNA3 and N2a-mLRP4 cells. The steady-state
levels and localization of Ab42 were determined by flow cytometry
and confocal microscopy, respectively (Fig. 2). Cells were
incubated with 500 nM FAM-Ab42 at 37uC for 24, 48 or 72 h
and the content of fluorescence per cell was quantified by FACS
and presented as a percentage of the levels in N2a-pcDNA3 at
each time point (Fig. 2A). Only a slight increase in the levels of
FAM-Ab42 was detected in N2a-mLRP4 cells after 24 h
incubation. However, twice the levels were detected at 48 h and
72 h in N2a-mLRP4 cells compared to N2a-pcDNA3 cells,
indicating that LRP1 minireceptor overexpression increases the
accumulation of FAM-Ab42 in N2a cells. It has been previously
demonstrated that endocytosed Ab enters the lysosomal pathway
in both neuronal and non-neuronal cells, and it has been suggested
that both exogenously added Ab42 and de novo synthesized Ab42
accumulate and aggregate in these organelles [10,12,13]. There-
fore, we analyzed the subcellular localization of internalized FAM-
Ab42 by confocal microscopy in N2a cells treated as before and
analyzed co-localization with lysosomes. For the visualization of
acidic organelles, a brief incubation with LysoTracker Red at
the end of the experiment was included (Fig. 2B). After 24 h
of incubation, a small amount of cell-associated Ab42 can be
detected in N2a-mLRP4 cells. However, this FAM-Ab42 does not
localize into acidic organelles, as evidenced by low co-localization
Ab42 Uptake through LRP1
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with LysoTracker. However, increased localization of Ab42 into
LysoTracker-positive organelles can be detected in both N2a-
pcDNA3 and N2a-mLRP4 cells after 48 and 72 h, and an
increased number of double-positive cells were detected in N2a-
mLRP4 cells compared to N2a-pcDNA3 cells after 48 h of
treatment. Given that pulse-chase experiments showed normal
lysosomal activity and increased FAM-Ab42 internalization in
LRP1-expressing cells (Fig. 1E), and because increased steady-state
levels of FAM-Ab42 were found in LRP1-expressing cells at longer
incubation times (Fig. 2), these results collectively indicate that
LRP1 minireceptor overexpression increases the uptake, delivery
and accumulation of Ab42 into lysosomes in N2a cells.
LRP1 increases Ab42 accumulation in GT1-7 and MEF
cells
To rule out cell type-specific effects and artifacts due to the
expression of LRP1 minireceptor, we performed similar FAM-
Ab42 uptake experiments in GT1-7 neuronal cells with reduced
endogenous LRP1 levels by siRNA knockdown (Fig. 3A), and in
mouse embryonic fibroblasts from both wild-type (MEF1) and
LRP1 knockout mice (MEF2) [38] (Fig. 3B). GT1-7 cells were
plated and treated as indicated in the Experimental Procedures and
GT1-7 and MEF cells were incubated with 500 nM of FAM-Ab42
at 37uC for 4 h. Steady-state levels of intracellular Ab42 were
determined by flow cytometric analysis of pronase-treated cells. A
decrease in the internalization of FAM-Ab42 was observed in
GT1-7 cells with decreased LRP1 levels, and in MEF2 cells
compared to MEF1. Depletion of LRP1 levels in both knockdown
and knockout cells were confirmed by Western blot (Fig. 3C).
Collectively, these results indicate that LRP1 expression directly
impacts the internalization of FAM-Ab42 in both neuronal and
non-neuronal cells.
LRP1 endocytosis is required for Ab42 accumulation in
neuronal cells
To determine whether the endocytic function of LRP1 is
required for Ab42 internalization and accumulation, we first
analyzed the effect of clathrin knockdown on the uptake of FAM-
Ab42 in N2a-mLRP4 cells. We decreased the expression of
clathrin heavy chain by lentiviral-mediated delivery of small
hairpin interfering RNA (shRNA) in N2a-mLRP4 cells and
analyzed cell surface levels of mLRP4 by FACS. Lentiviral-
mediated knockdown of clathrin heavy chain substantially
decreases the protein levels of clathrin heavy chain and evokes a
twofold-increase in the levels of cell surface mLRP4 in N2a cells
(Fig. 4A), consistent with an impairment of clathrin-mediated
endocytosis of this LRP1 minireceptor. We therefore tested the
uptake of FAM-Ab42 in similarly infected cultures. Approximately
a twofold decrease in FAM-Ab42 uptake was observed in clathrin
knocked down cells compared to cells infected with a control,
Figure 1. LRP1 minireceptor increases the uptake of Ab42 in
N2a-mLRP4 cells. A, cell lysates from N2a cells stably expressing LRP1
minireceptor (N2a-mLRP4) or empty pcDNA3 vector (N2a-pcDNA3) were
analyzed by 7.5% SDS-PAGE and Western blotted with anti-HA or anti-
LRP1 antibodies. Both the endoplasmic reticulum precursor (open
arrowhead) and the processed forms after furin cleavage (closed
arrowhead) are readily detected with anti-HA antibodies. The level of
LRP1-85 in N2a-pcDNA3 cells is negligible compared to that in N2a-
mLRP4 cells. B, flow cytometric analyses of N2a cells stably transfected
with pcDNA3 and mLRP4. Negative controls without primary antibody
are indicated with light lines, whereas the signals from cell surface
receptor staining are shown with dark lines. 84% of N2a-mLRP4 showed
cell surface expression of the LRP1 minireceptor. C, LRP1 minireceptor
expression increases the endocytosis of RAP in N2a cells. N2a-pcDNA3
and N2a-mLRP4 cells were incubated with 500 nM Alexa488-RAP at 37uC
for 30 min, then fixed and analyzed by fluorescence microscopy. D, flow
cytometric analysis from experiments as in C. N2a-pcDNA3 and N2a-
mLRP4 cells were detached and additionally treated with pronase to
remove cell surface-associated RAP. Quantification of FACS experiments
indicates that N2a-mLRP4 cells internalize approximately 8 times more
RAP than N2a-pcDNA3 cells. ** p,0.01, t-test. n = 3. E, LRP1 minireceptor
expression increases the endocytosis of Ab42 in N2a cells. N2a-pcDNA3
and N2a-mLRP4 cells were incubated with 5 mM FAM-Ab42 for 1 h at 4uC
and warmed to 37uC for 0.5, 4, 8 or 24 h, then fixed and examined by
confocal microscopy. In N2a-mLRP4 cells, FAM-Ab42 accumulation
peaked 4 h after warming and decreased over time, suggesting that
intracellular Ab42 is eventually delivered for degradation.
doi:10.1371/journal.pone.0011884.g001
Ab42 Uptake through LRP1
PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11884
empty lentivirus (Fig.4B). As a control for specificity, we analyzed
the uptake of a FAM-Ab42 peptide that contained the same amino
acid composition but in a scrambled sequence. Very little uptake
of fluorescently labeled scrambled FAM-Ab42 was detected in
both control and clathrin knockdown N2a-mLRP4 cells, indicat-
ing that Ab42 internalization requires the intact sequence of Ab42.
Together, these results indicate that clathrin-mediated endocytosis
is a critical pathway for Ab42 uptake and strongly suggest that
neuronal Ab42 uptake is a receptor- mediated process that
requires the endocytic properties of LRP1. To further confirm this,
we specifically targeted the endocytic function of mLRP4 and
analyzed the internalization of FAM-Ab42 in LRP1 endocytosis-
deficient cells. The molecular determinants of LRP1 endocytosis
reside in its cytoplasmic tail [39,40]. We have previously
demonstrated that, despite reaching the plasma membrane, a
deletion of the complete cytoplasmic tail of mLRP4 (mLRP4-
Tless) impairs its endocytic function [34]. We therefore prepared
N2a-mLRP4-Tless stable cell lines and first characterized the
endocytic properties of the LRP1 minireceptor in this neuronal cell
type. Flow cytometric analysis indicates that deletion of the mLRP4
cytoplasmic tail increases its distribution at the cell surface (Fig. 4C),
consistent with impaired endocytosis. Additionally, the endocytosis
rate for 125I-RAP was decreased in these cells (Fig. 4D). We
compared the uptake of FAM-Ab42 in N2a-pcDNA3, N2a-mLRP4
and N2a-mLRP4-Tless by FACS in both pronase-treated and
untreated cells. Again, cell-associated FAM-Ab42 increases in N2a-
mLRP4 cells compared to N2a-pcDNA3 cells. Notably, FAM-Ab42
uptake was similar in N2a-mLRP4-Tless and N2a-pcDNA3 cells,
consistent with a role for LRP1 endocytosis in Ab42 uptake (Fig. 4E).
Therefore, impairing the endocytic function of mLRP4 by clathrin
knockdown or by the removal of its cytoplasmic tail decreased
FAM-Ab42 uptake, demonstrating that LRP1 endocytosis is
required for Ab42 internalization in N2a cells.
Increased cellular toxicity in N2a-mLRP4 cells incubated
with Ab42
It has been previously demonstrated that increased delivery of
Ab42 into lysosomes increases leakage of the lysosomal contents
into the cytosol and hence induces cell toxicity [20,21], an effect
that is increased by apoE4 and might depend on LRP1 function.
We hypothesized that Ab42 treatment might increase cell death in
mLRP4-overexpressing N2a cells because we detected increased
co-localization of Ab42 with lysosomes in these cells. We treated
N2a-pcDNA3 and N2a-mLRP4 cells with Ab42 for 24, 48 and
Figure 3. LRP1 mediates internalization and accumulation of
Ab42 in GT1-7 and MEF cells. A, LRP1 knockdown decreases Ab42
accumulation in GT1-7 cells. GT1-7 cells were transiently transfected
with LRP1 siRNA or with control, scrambled siRNA. After 72 h, cells were
treated with 500 nM FAM-Ab42 for 4 h and intracellular Ab42 was
determined by flow cytometric analyses of pronase-treated cells as
described in the Experimental Procedures. B, decreased Ab42 accumu-
lation in mouse embryonic fibroblasts from LRP1 knockout mice. Wild
type (MEF1) and LRP1 knockout (MEF2) fibroblasts were treated with
500 nM FAM-Ab42 for 4 h, and intracellular Ab42 was determined by
flow cytometric analyses. ** p,0.01, t-test. n = 3. C, cell lysates from
GT1-7 and MEF cells treated as in A and B, analyzed by 7.5% SDS-PAGE,
and Western blotted with anti-LRP1 antibodies. Levels of LRP1 were
efficiently decreased in both cell types.
doi:10.1371/journal.pone.0011884.g003
Figure 2. Increased accumulation of intracellular Ab42 within
lysosomes in LRP1 minireceptor-expressing cells. A, increased
Ab42 accumulation in LRP1 minireceptor-expressing cells. N2a-mLRP4
and N2a-pcDNA3 cells were treated with 500 nM of FAM-Ab42 at 37uC
for 24, 48 and 72 h, and steady-state levels of intracellular Ab42 were
determined by flow cytometric analyses of pronase-treated cells as
described in the Experimental Procedures. N2a-mLRP4 cells showed
increased Ab42 accumulation compared to N2a-pcDNA3 cells starting
at 48 h of Ab42 incubation. ** p,0.01, *** p,0.001, t-test. n = 3.
B, increased co-localization of intracellular Ab42 and lysosomes in N2a-
mLRP4 cells. N2a-pcDNA3 and N2a-mLRP4 cells were grown in glass
chamber slides and treated with 500 nM of FAM-Ab42 at 37uC for 24, 48
and 72 h. Lysosomes were labeled with LysoTracker 30 min before the
end of each incubation. Cells were then fixed and analyzed by confocal
microscopy. Intracellular accumulated Ab42 was highly co-localized
with LysoTracker and increased over time in N2a-mLRP4 cells.
doi:10.1371/journal.pone.0011884.g002
Ab42 Uptake through LRP1
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72 h and assessed cell viability by reduction of the MTS redox dye.
Ab42 was prepared identically to the FAM-Ab42 experiments. A
slight yet significant decrease in cell viability was detected only in
mLRP4- expressing cells after 72 h of incubation with 3 mM
Ab42, suggesting that LRP1-mediated delivery of Ab42 into
lysosomes might not be sufficient to trigger cell death in N2a cells
at early time points or at lower Ab42 concentrations (Figure 5).
Together, our results demonstrate that LRP1 mediates neuronal
Figure 4. LRP1 endocytosis is required for Ab42 uptake and accumulation in N2a cells. A, clathrin heavy chain (CHC) knockdown increases
cell surface levels of mLRP4. N2a-mLRP4 cells were infected with CHC shRNA lentivirus or pLKO, control lentivirus. The levels of cell surface and total
pools of mLRP4 were determined by flow cytometric analyses with anti-HA antibody in non-permeabilized and saponin-treated cells, respectively.
The surface-to-total ratio were calculated and plotted as fold-change to control-infected cells. Right panel, decreased CHC levels and normal mLRP4
levels in transduced N2a-mLRP4 cells were verified by Western blot from sister cultures. B, CHC knockdown decreases accumulation of Ab42 in N2a-
mLRP4 cells. N2a-mLRP4 cells infected with clathrin heavy chain lentivirus as in A) were treated with 500 nM of FAM-Ab42 or the corresponding
control, scrambled peptide for 48 h. The intracellular level of FAM-Ab42 was determined by flow cytometric analyses of pronase-treated cells.
C, deletion of LRP1 tail increases cell surface levels of mLRP4. The cell surface and total pools of the LRP1 minireceptor were determined by flow
cytometric analyses with anti-HA antibody as in A in N2a-mLRP4 cells and in N2a cells stably transfected with a deletion variant lacking the
cytoplasmic tail of mLRP4 (mLRP4-Tless). The surface-to-total ratios were then calculated and plotted as fold-change to N2a-mLRP4 cells. Right panel,
HA blot showing the expression level of minireceptors in N2a stable cell lines. D, deletion of LRP1 tail decreased the mLRP4 endocytosis rate in N2a
cells. N2a-mLRP4 and N2a-mLRP4-Tless cells were incubated with 5 nM 125I-RAP at 4uC for 60 min, and then shifted to 37uC for the indicated times. At
each time point, the amounts of ligand that is either internalized or that remains at the cell surface were determined and the ratios of internalized to
total cell-associated ligand were plotted against time. Values are the average of triple determinations with the S.D. indicated by error bars. E, impaired
LRP1 endocytosis rate decreases accumulation of Ab42 in N2a-mLRP4 cells. N2a-pcDNA3, N2a-mLRP4 and N2a-mLRP4-Tless cells were treated with
500 nM of FAM-Ab42 or the corresponding control, scrambled peptide for 48 h and the cell-associated (without pronase) and intracellular (with
pronase) levels of Ab42 were determined by flow cytometric analyses.
doi:10.1371/journal.pone.0011884.g004
Ab42 Uptake through LRP1
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endocytosis of Ab42, which leads to eventual lysosomal accumu-
lation at high Ab42 concentrations and slightly decreases neuronal
viability.
Discussion
The importance of LRP1 in Ab metabolism has been
recognized because of its ability to mediate brain efflux at the
blood-brain barrier and because of its role in modulating APP
processing to Ab[31]. Here, we show that LRP1 endocytosis plays
an additional role in Ab42 uptake and delivery into intracellular
compartments of neuronal cells. A faster transient accumulation of
intracellular Ab42 was detected in N2a-mLRP4 cells compared to
N2a-pcDNA3 cells after 4 h of endocytosis in binding-endocytosis
experiments (Fig. 1E). However, continuous uptake experiments
suggest that, over time, Ab42 might escape the degradation
pathway and start to accumulate, which is evident after 48 h of
incubation (Fig. 2B). It is interesting that N2a-pcDNA3 cells
showed a delayed accumulation of Ab42 in binding-endocytosis
experiments assays, with a peak at 8 h after warming. Because
N2a cells express very low levels of endogenous LRP1 (Fig. 1A,
anti-LRP1 blot), and given that endogenous LRP1 and the
mLRP4 minireceptor possess similar kinetics of endocytosis, these
results suggest that an LRP1- independent pathway is responsible
for Ab42 internalization in N2a-pcDNA3 cells, which mediate
slower kinetic delivery into lysosomes. The LRP1 minireceptor
mLRP4 might compete for these Ab42 cell surface binding sites
and give rise to the rapid internalization observed in N2a-mLRP4
cells. Notably, at 8 h after warming up, N2a-mLRP4 cells
exhibited decreased levels of Ab42 in our imaging experiments,
indicating that the degradation of Ab42 by the LRP1-dependent
pathway is very efficient. The mechanisms that are responsible for
Ab42 accumulation in N2a-mLRP4 cells in the continuous
endocytosis experiments are unknown. However, it is tempting
to speculate that the constant presence of relatively high
concentration of Ab42 leads to high Ab42 concentrations in the
lysosomes that might exceed its degradation capacity. Our data
demonstrate that the endocytic activity of LRP1 is required for
Ab42 internalization and accumulation because both clathrin
heavy chain knockdown and deletion of the LRP1 tail decreased
the levels of intracellular Ab42.
Previous reports addressed the question of whether LRP1
mediates the uptake of Ab into neurons. Experiments performed
in cortical neurons from Tg2576 APP transgenic mice suggested
that LRP1 might endocytose and degrade endogenously produced
Ab complexed with LRP1 ligands a2M and lactoferrin [41].
However, these experiments relied primarily on the use of RAP to
define the LRP1 pathway. Because RAP also inhibits binding of
ligands to several other members of the LDLR family, the specific
function of LRP1 in these studies was not clear. Endogenously
produced Ab adds a second level of complexity to that study [41]
as Ab might be either produced in the endocytic compartments or
trafficked there directly without secretion. Similarly, the uptake of
Ab40 complexed with apoE has been previously characterized by
FACS into purified rat brain synaptosomes, but again only RAP
was used to define the LRP1 pathway [42]. To our knowledge, our
study is the first to report changes in Ab trafficking by direct
targeting the expression and endocyitic function of LRP1 in neural
cells. We show that in neural cells, overexpressing LRP1
minireceptor increases Ab42 internalization and accumulation,
whereas knockdown of endogenous LRP1 decreases these
processes. These findings establish a direct role for LRP1 in
neuronal Ab42 uptake, degradation and/or accumulation. It is
worth mentioning that induction of Ab accumulation in the brains
of apoE-targeted replacement mice through inhibition of the
extracellular Ab protease neprilysin [22] showed that Ab
accumulates intracellularly along with apoE in CA1 and septal
neurons of apoE4 targeted-replacement mice, and that this effect
correlates with increased LRP1 levels in these neurons [22,43].
This in vivo evidence is in line with our current findings in cultured
neurons and our previous studies in mouse brain [34] which
demonstrated that LRP1 function is critical for the uptake and
accumulation of Ab42. Since apoE3 and apoE4 bind similarly to
LRP1 [44], additional factors might account for the apoE isoform-
specific effects on neuronal Ab42 accumulation. We are currently
evaluating the contribution of differential trafficking of apoE
isoforms in neuronal Ab42 metabolism and accumulation.
Kim et al. have recently demonstrated that LDLR, the founding
member of the LDLR gene family to which LRP1 belongs,
negatively regulates apoE levels in the brain and promotes Ab
clearance in vivo [45]. They elegantly showed that as little as a
twofold increase in brain LDLR decreases apoE levels and
enhances the elimination of extracellular Ab from the brain
interstitial fluid, with a concomitant decrease in amyloid plaque
formation. Although it remains to be established whether the effect
of LDLR on Ab metabolism is apoE dependent, this finding
identifies another apoE endocytic receptor that modulates Ab
metabolism in the brain. It is interesting that LDLR and LRP1
have overlapping binding properties for apoE3 and apoE4;
however, LRP1’s high expression level in the brain and fast
endocytosis rate likely make this receptor an important candidate
for Ab metabolism in the brain. Supporting this hypothesis, we
have previously shown that LRP1 knockout in forebrain neurons
leads to increased brain apoE levels in mice [46]. On the other
hand, Ab42 immunoreactivity was significantly decreased in
PDAPP mice lacking apoE, supporting a role for apoE in
mediating Ab uptake in vivo [34]. More detailed characterization
of APP, apoE, LDLR and LRP1 is required to define the precise
interplay among these lipid metabolic proteins.
Figure 5. Increased susceptibility to Ab42-mediated cell death
in LRP1 minireceptor-expressing cells. N2a-pcDNA3 and N2a-
mLRP4 cells were incubated with increasing concentrations of Ab42 for
24, 48 and 72 h and cell viability was assessed by the reduction of the
MTS dye. Decreased viability was detected only after 72 h incubation
with a high concentration of Ab42 in LRP1 minireceptor expressing
cells. * p,0.05, t-test. n = 3.
doi:10.1371/journal.pone.0011884.g005
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The increased accumulation of Ab42 in lysosomes of LRP1-
expressing cells (Fig. 2B) and its correlation with decreased cell
viability (Fig.5) is intriguing. Imaging experiments of endocytosed
Ab42 suggest that a large portion of LRP1-delivered Ab42 is
degraded. However, when the amount of Ab42 exceeds lysosomal
degradation capacity, Ab42 likely accumulates and aggregates. It
has been demonstrated that localization of Ab42 into lysosomes is
toxic to neurons, in particular in the presence of apoE4 [20,21,22].
The acidic environment of the lysosomal compartment might be
key for the potentiating effect of apoE4 on Ab42-induced
lysosomal leakage and apoptosis, as demonstrated by Ji et al.
Notably, this group found that reducing LRP1 levels by siRNA
knockdown decreases the stimulatory effects of apoE4 [21], which
is consistent with our finding that LRP1 mediates endocytosis and
lysosomal trafficking of Ab42 in neuronal cells. In addition, it has
been demonstrated that LRP1 plays a role in the TGFb-induced,
Ab42-mediated lysosomal leakage [47,48]. Our neural viability
experiments showed that cell viability was slightly decreased after
72 h of incubation with a high concentration of Ab42 in LRP1-
expressing cells (Fig. 5). It will be of great interest to evaluate
whether increased co-localization of Ab42 with lysosomes in
apoE4-treated N2a-mLRP4 cells leads to more severe lysosome-
associated neuronal toxicity in our cell-based system.
Increased accumulation of intracellular Ab has various
pathological effects on cell and organelle function, including
proteasome inhibition, mitochondrial abnormalities, tau hyper-
phosphorylation and presumably, the seeding of amyloid plaques
after neuronal cell death [49]. Immunohistochemical analyses of
AD brains strongly suggests that amyloid plaques arise when an
Ab-accumulating neuron undergoes a single lysis event [50,51]. In
support of this, 3xTg-AD mice treated with anti-Ab antibodies
show a parallel decrease of extracellular amyloid deposits and
intraneuronal Ab in pyramidal cells, which suggests there is a
dynamic relationship between the intracellular and extracellular
pools of Ab [52]. Therefore, it is conceivable that the endocytic
activity of LRP1 might contribute to the appearance of plaques by
increasing the internalization of Ab, with a consequent decrease in
neuronal function and viability and release of amyloid seeds into
the brain parenchyma. Our LRP1-overexpressing mouse model,
however, did not show an increase in the amyloid plaque burden
when crossed to PDAPP amyloid model mice [53]. Additional
compensatory mechanisms mediated by LRP1, including the
activation of survival signaling pathways, might prevent the
adverse effects of intraneuronal Ab accumulation in vivo and its
subsequent release. It is worth mentioning that LRP1 is indeed a
signaling receptor capable of activating survival pathways
including ERK, Akt and b-catenin [54,55,56,57,58]. Among these
pathways, Akt is regulated by LRP1 in differentiated neurons and
targeted by intraneuronal Ab[57,59]. We propose that dysregu-
lated neuronal functions of LRP1 in Ab production, clearance, as
well as cell survival might contribute to the neuronal pathology in
AD.
In conclusion, we show that modulation of LRP1 expression or
its endocytic function directly impacts neuronal Ab42 uptake,
degradation and/or accumulation. These results provide strong
evidence that an LRP1-mediated pathway is crucial for Ab42
trafficking and metabolism in neurons.
Materials and Methods
Reagents and Antibodies
FAM-Ab42 peptide (23526) and scrambled FAM-Ab42 peptide
(60892) were from Anaspec (Fermont, CA). Unlabeled Ab42 was
obtained from Bachem (Torrance, CA). Anti-HA monoclonal
antibody (12CA5) was from Babco (Richmond, CA). Anti-Clathrin
Heavy Chain monoclonal antibody was from Sigma (St Louis,
MO). Anti-LRP1-85 was a rabbit polyclonal antibody produced
in-house. High glucose Dulbecco’s modified Eagle’s medium
(DMEM, D-5796), fetal bovine serum, G418, sodium azide,
CaCl2, cell dissociation solution, pronase, PMSF, saponin and
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP; catalog number H8508)
were from Sigma (St Louis, MO). OptiMEM-I, Lipofectamine
2000 and LysoTrackerH Red DND-99 were from Invitrogen
(Carlsbad, CA). Immobilon-P PVDF membrane was from
Millipore (Bedford, MA). 8-well Lab-Tek chambers (catalog
number 155411) were from Nunc (Rochester, NY). Complete
EDTA free cocktail of protease inhibitors was from Roche Applied
Sciences (Indianapolis, IN).
Cell culture and stable cell lines
Neuro-2A (N2a) is a mouse neuroblastoma cell line available
from the American Type Culture Collection (CCL-131). Sub-
confluent N2a cells were maintained in growth media (1:1
DMEM:OptiMEM-I mixture containing 5% FBS and 2 mM L-
glutamine). For generation of stable cell lines, N2a cells were
transfected with Lipofectamine 2000 and selected in growth media
supplemented with 800 mg/mL G418 for at least 2 weeks until the
verification of transgene expression. The immortalized hypotha-
lamic neuronal cell line GT1–7 [60] and MEF cells were grown in
DMEM media containing 10% FBS and 2 mM L-glutamine. For
all the experiments, cells were kept at low passage number (,10)
and were routinely analyzed for Mycoplasma contamination using
the MycoSensor PCR assay kit (Stratagene, LaJoya, CA).
FACS analysis of surface and total ratio and purity of
clones
Sub-confluent N2a cells in 100 mm Petri dishes were washed
twice in PBS and non-enzymatically detached by incubating 5 min
at 37uC in cell dissociation solution. After washing in growth
media, samples were divided in two parts and half of the samples
were kept in a minimal volume of PFN buffer (PBS supplemented
with 1.5% FBS and 0.1% sodium azide) for the non-permeabilized
group. The remaining cells were resuspended in PFN containing
0.05% saponin and gently rocked for 30 min at 4uC. After
washing with growth media, permeabilized and non-permeabi-
lized cells were incubated with 50 mg/mL anti-HA antibody for
2 h at 4uC. After two washes with PFN, cells were incubated with
50 mg/mL goat anti-mouse-Ig fluorescein isothiocyanate as a
secondary antibody and similarly incubated for 45 min. Cells were
washed twice, fixed in PFN-1% PFA and analyzed in a
FACSCalibur cytometer (BD Bioscience) equipped with an argon
ion laser. Laser excitation of 488 nm for fluorescein isothiocyanate
was used. Twenty thousand cells from each sample were analyzed
and histograms were generated using CellQuest software. After the
subtraction of blank controls lacking primary antibody, the
geometric means of fluorescence intensity were obtained for
non-permeabilized and permeabilized samples, representing
surface and total minireceptor levels, respectively. The surface-
to-total ratio was calculated and utilized for comparison purposes.
Unpermeabilized conditions were used to determine the purity of
stable cell lines.
Immunoblot Analysis
After indicated treatments, cells were washed twice in PBS and
cell lysates were prepared in PBS containing 1% TX-100,
supplemented with 1 mM PMSF and a protease inhibitor cocktail.
After 30 min on ice, cells were briefly vortexed and cell debris
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discarded by centrifugation at 10,0006g for 10 min at 4uC. 20 mg
of protein was resolved by reducing 10% SDS-PAGE and
transferred to PVDF membranes overnight. After the membranes
were blocked, proteins were detected by using 1:1,000 dilution of
primary antibodies for commercial antibodies or 1 mg/mL of
purified anti-LRP polyclonal IgG. The immunoblotting was
followed by detection with a horseradish peroxidase-conjugated
secondary antibody and enhanced chemiluminiscence substrate
(GE Healthcare, Uppsala, Sweden). Bands on films were scanned
using Quantity-One software (Bio-Rad, Hercules, CA).
Preparation of Ab42 and RAP
Synthetic FAM-Ab42 was resuspended essentially as described
by Stine et al. to yield an essentially assembly-free/monomeric
preparation [61]. Briefly, 0.1 mg vial of FAM-Ab42 was
resuspended in HFIP, divided into aliquots and dried in a current
of nitrogen gas. FAM-Ab42 and Ab42 protein films were
thoroughly resuspended in DMSO at 5 mM and immediately
diluted with water to form a 100 mM Ab42 stock solution. To
avoid aggregation of the peptides during treatment of cells,
resuspended aliquots were used within 30 min after resuspension.
RAP protein was routinely produced in our lab and was labeled
with an Alexa-488 labeling kit (Millipore, Bedford, MA) and stored
at 280uC until use [23].
In vitro FAM-Ab42 uptake and accumulation assays by
laser scanning confocal microscopy
For the imaging experiments, stable N2a cells were plated into
an 8-well chambered coverglass at 16,250 cells/cm2 with one
independent chambered coverglass for each time point, and cells
were grown overnight. For uptake experiments, cells were washed
three times with cold DMEM and binding of 5 mM FAM-Ab42
was performed in DMEM at 4uC for 1 h. After binding, unbound
FAM-Ab42 was removed by three washes with cold PBS. To
initiate the uptake, cells were switched to 37uC for different time
periods by adding pre-warmed internalization media (DMEM
containing 10% FBS and 2 mM L-glutamine) and bringing the
chambered coverglass back to the incubator until completion of
the kinetic time point. For steady-state accumulation experiments,
cells were washed twice with PBS and incubated for the indicated
periods of time with pre-warmed internalization media containing
500 nM FAM-Ab42. In some experiments, 100 nM LysoTracker
Red probe was added 30 min prior to the end of the experiment.
Cells were then fixed and analyzed by a confocal laser scanning
microscope (Fluoview 500, Olympus) using a 40x objective lens.
The signal corresponding to Ab42 was visualized in the fluorescein
channel and LysoTracker was visualized in the Alexa-569 channel.
Quantification of Ab42 accumulation by FACS analysis
For quantification of Ab uptake experiments, stable N2a cells
were plated into 12-well plates at 16,250 cells/cm2 and grown
overnight. Similar to imaging assays, cells were washed twice with
PBS and incubated for the indicated periods of time with pre-
warmed internalization media containing 500 nM FAM -Ab42.
After incubation, cells were washed twice with PBS and non-
enzymatically detached as before in 500 mL cell dissociation
solution. Cells were sequentially washed once with 1 mL of cold
internalization media and twice with 2 mL cold PFN. Cells were
finally resuspended in PFN-1% PFA and analyzed by FACS as
before. For MEF-1 and MEF-2 experiments, 5,000 cells/cm2 were
plated in 12-well plates the day before. Cells were then washed
twice with PBS and incubated 4 h with pre-warmed internaliza-
tion media containing 500 nM FAM-Ab42. After completion of
the incubation time, cells were processed by FACS analysis as
described above for N2a cells.
Kinetic Analysis of Endocytosis
Kinetic analysis of receptor-mediated endocytosis was carried
out as described previously [40]. Briefly, stably transfected N2a
cells were plated at a density of 26105 cells/well in a 12-well plate
and used after overnight culture. Cells were rinsed twice with cold
PBS and then incubated in 0.5 ml ice-cold ligand binding buffer
(DMEM-5 mM CaCl2 containing 0.6% bovine serum albumin)
with 5 nM 125I-RAP. The binding of iodinated proteins was
carried out at 4uC for 60 min with gentle rocking. Unbound
ligand was removed by washing cell monolayers three times with
cold binding buffer. Ice-cold stop/strip solution (0.2 M acetic acid,
and 0.1 M NaCl, pH 2.6) was added to one set of plates without
warming and kept on ice. The remaining plates were then placed
in a 37uC water bath and 0.5 ml of pre-warmed ligand binding
buffer was quickly added to the cell monolayers to initiate
internalization. After each time point, the plates were placed on
ice, and the ligand binding buffer was replaced with ice-cold strip/
stop solution. Ligand remaining on the cell surface was stripped by
incubation of cell monolayers with ice-cold stop/strip solution for
10 min and counted. The sum of internalized and cell-surface
ligand after each assay was used as the maximum potential
internalization. The fraction of internalized ligand at each time
point was calculated and plotted.
LRP1 and clathrin heavy chain knockdown
LRP1 knockdown was carried out in GT1-7 cells by siRNA
transfection using Lipofectamine 2000 (Invitrogen, Carlslab, CA)
and 120 nM of dsRNA duplex (Ambion, Austin, TX). Briefly, cells
were plated in 6-well plates the day before transfection and grown
overnight. Scrambled and LRP1 siRNA duplexes were generated
according to the manufacturer’s instruction and complexed with
Lipofectamine 2000 as previously described [62]. FAM-Ab42
experiments were performed 72 h after siRNA transfection and
analyzed as previously described for N2a cells. For clathrin heavy
chain knockdown, shRNA lentiviruses were produced in the Viral
Vectors Core facility at Washington University School of
Medicine. In brief, 293T cells were transfected with pLKO.1-
derived constructs together with the pHR’8.2DR and pCMV-
VSV-G packaging systems as previously described [63]. Condi-
tioned media were concentrated by ultracentrifugation, titrated
against HT1080 cells and kept frozen in 20 mL aliquots at 280uC
until use. N2a cells were plated at 16,250 cells/cm2 in 100 mm
Petri dishes and grown overnight. N2a cells were infected two
times by incubating the cultures with 16107 transforming units of
lentivirus overnight. After the second infection, the cells were split
into 12-well plates for Western blot and FAM-Ab42 accumulation
experiments or were kept an additional day without being split up
for cell surface and total mLRP4 levels determination by FACS.
MTS redox assay in Ab42 treated cells
N2a-pcDNA3 and N2a-mLRP4 cells were plated at
16,250 cells/cm2 in 48-well plates and grown overnight. Serial
dilutions of freshly prepared synthetic Ab42 were prepared by
diluting the Ab42 stock with internalization media. Culture media
was then replaced with media containing 0, 1 or 3 mM Ab42 and
cells were incubated for an additional 24, 48 or 72 h. Cell viability
was measured by using one-solution cell titer kit at each
corresponding time point (Promega, Madison, WI). After 4 h
labeling, the soluble reduced formazan product was quantified by
directly reading the plate in a Bio-Tek plate reader. After
background subtraction from media-only containing wells, results
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were represented as % of the corresponding control and untreated
N2a cells.
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